Hengkang Medical Group Co Ltd
SZSE:002219
Intrinsic Value
Hengkang Medical Group Co. Ltd. is engaged in the manufacturing, sale, research and development of traditional Chinese medicines. [ Read More ]
The intrinsic value of one
Hengkang Medical Group Co Ltd
stock under the Base Case scenario is
1.99
CNY.
Compared to the current market price of 2.36 CNY,
Hengkang Medical Group Co Ltd
is
Overvalued by 16%.
Hengkang Medical Group Co Ltd's market capitalization is 8B CNY.
Hengkang Medical Group Co Ltd stock price is 2.36 CNY.
Hengkang Medical Group Co Ltd stock (1.99 CNY) is 16% less than its price (2.36 CNY).
Hengkang Medical Group Co Ltd stock (1.23 CNY) is 48% less than its price (2.36 CNY). Open DCF Valuation
Hengkang Medical Group Co Ltd stock price (2.36 CNY) is 14% less than its Relative Value (2.75 CNY). Open Relative Valuation
Hengkang Medical Group Co Ltd.
Hengkang Medical Group Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 10%.
Hengkang Medical Group Co Ltd has positive Free Cash Flow for the last twelve months.
Hengkang Medical Group Co Ltd's Revenue has grown by 16% over the past 12 months.
Hengkang Medical Group Co Ltd's Revenue has been growing by 8% per year for the last 3 years.
Hengkang Medical Group Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.88.
Hengkang Medical Group Co Ltd's ROE (Return on Equity) for the past 12 months is very low and is equal to 2%.
Hengkang Medical Group Co Ltd has positive Operating Income for the last twelve months.
Hengkang Medical Group Co Ltd has positive three-year average ROIC (Return on Invested Capital): 5%. The company is efficient at using invested capital to generate operating income.
Hengkang Medical Group Co Ltd's long-term assets (6B CNY) exceed its long-term liabilties (4B CNY).
Hengkang Medical Group Co Ltd has positive Gross Profit for the last twelve months.
Hengkang Medical Group Co Ltd has positive Net Income for the last twelve months.
Hengkang Medical Group Co Ltd's ROE (Return on Equity) has significantly increased in the last 3 years from -55% to 2%.
Hengkang Medical Group Co Ltd's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from 40% to 10%.
Hengkang Medical Group Co Ltd's short-term liabilties (3B CNY) exceed its short-term assets (2B CNY).
Hengkang Medical Group Co Ltd has positive Net Debt. This means that the company has more debt (2B CNY) than cash and short-term investments (557m CNY).
Hengkang Medical Group Co Ltd's Altman Z-Score is very low and is equal to 1.23.
Hengkang Medical Group Co Ltd has negative three-year average ROE (Return on Equity): -20%. The company is not efficient at transforming stockholders' equity into net income.
Valuation Backtest
Hengkang Medical Group Co Ltd
Run backtest to discover the historical profit from buying and selling
Hengkang Medical Group Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Hengkang Medical Group Co Ltd
Balance Sheet Decomposition
Hengkang Medical Group Co Ltd
| Current Assets | 2B |
| Cash & Short-Term Investments | 557m |
| Receivables | 1.1B |
| Other Current Assets | 277.8m |
| Non-Current Assets | 4.1B |
| Long-Term Investments | 6.9m |
| PP&E | 2.6B |
| Intangibles | 1.3B |
| Other Non-Current Assets | 225.6m |
| Current Liabilities | 2.9B |
| Accounts Payable | 1.3B |
| Accrued Liabilities | 139.8m |
| Short-Term Debt | 1.1B |
| Other Current Liabilities | 427.3m |
| Non-Current Liabilities | 961.2m |
| Long-Term Debt | 885.7m |
| Other Non-Current Liabilities | 75.5m |
Earnings Waterfall
Hengkang Medical Group Co Ltd
|
Revenue
|
3.7B
CNY
|
|
Cost of Revenue
|
-2.6B
CNY
|
|
Gross Profit
|
1.1B
CNY
|
|
Operating Expenses
|
-927.2m
CNY
|
|
Operating Income
|
145.6m
CNY
|
|
Other Expenses
|
-112m
CNY
|
|
Net Income
|
33.6m
CNY
|
Free Cash Flow Analysis
Hengkang Medical Group Co Ltd
Profitability Score
Profitability Due Diligence
Hengkang Medical Group Co Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
Hengkang Medical Group Co Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Hengkang Medical Group Co Ltd's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Score
Hengkang Medical Group Co Ltd's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Hengkang Medical Group Co Ltd
Shareholder Return
Price
Hengkang Medical Group Co Ltd
| Average Annual Return | 14.67% |
| Standard Deviation of Annual Returns | 66.54% |
| Max Drawdown | -74% |
| Market Capitalization | 8B CNY |
| Shares Outstanding | 3 410 758 753 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Hengkang Medical Group Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Hengkang Medical Group Co. Ltd. is engaged in the manufacturing, sale, research and development of traditional Chinese medicines. The company is headquartered in Chengdu, Sichuan and currently employs 7,622 full-time employees. The company went IPO on 2008-03-06. In addition, The Company also engages in the research and development, production and manufacture of Chinese patent medicines, Chinese herbal medicines and Chinese medicinal materials, medical devices, medical institution preparations, daily chemicals and health products. The firm operates its business within the domestic market and overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one
Hengkang Medical Group Co Ltd
stock under the Base Case scenario is
1.99
CNY.
Compared to the current market price of 2.36 CNY,
Hengkang Medical Group Co Ltd
is
Overvalued by 16%.
You don't have any saved screeners yet
